Veerle Bulteel

819 total citations
10 papers, 629 citations indexed

About

Veerle Bulteel is a scholar working on Genetics, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Veerle Bulteel has authored 10 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Veerle Bulteel's work include Inflammatory Bowel Disease (5 papers), Cystic Fibrosis Research Advances (3 papers) and Tracheal and airway disorders (3 papers). Veerle Bulteel is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Cystic Fibrosis Research Advances (3 papers) and Tracheal and airway disorders (3 papers). Veerle Bulteel collaborates with scholars based in Belgium, United States and France. Veerle Bulteel's co-authors include Benny Geypens, Peter Suenaert, Paul Rutgeerts, Gert Van Assche, Maja Noman, Karel Geboes, Jan Ceuppens, Liesbeth Lemmens, Séverine Vermeire and Elly Den Hond and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Inflammatory Bowel Diseases.

In The Last Decade

Veerle Bulteel

10 papers receiving 613 citations

Peers

Countries citing papers authored by Veerle Bulteel

Since Specialization

Citations

This map shows the geographic impact of Veerle Bulteel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veerle Bulteel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veerle Bulteel more than expected).

Fields of papers citing papers by Veerle Bulteel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veerle Bulteel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veerle Bulteel. The network helps show where Veerle Bulteel may publish in the future.

Co-authorship network of co-authors of Veerle Bulteel

This figure shows the co-authorship network connecting the top 25 collaborators of Veerle Bulteel. A scholar is included among the top collaborators of Veerle Bulteel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veerle Bulteel. Veerle Bulteel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Disease-specific clinical trials networks: the example of cystic fibrosis 2016 ·European Journal of Pediatrics ·K. De Boeck, Veerle Bulteel, Isabelle Fajac	10
2	The European Cystic Fibrosis Society–Clinical Trials Network: an international network to optimize clinical research for a rare disease 2013 ·Clinical Investigation ·Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs, Pavel Dřevı́nek, L. Pereira, Christine Dubois, Andreas Reimann, K. De Boeck	3
3	Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway 2011 ·Alimentary Pharmacology & Therapeutics ·Vicky De Preter, Karel Geboes, Veerle Bulteel, (unknown), Peter Suenaert, Paul Rutgeerts, Kristin Verbeke	37
4	Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN) 2011 ·Journal of Cystic Fibrosis ·K. De Boeck, Veerle Bulteel, Harm Tiddens, (unknown), Isabelle Fajac, Richard Conway, (unknown), Alan R Smyth, (unknown), (unknown), Behrouz Kassaï, J.S. Elborn	16
5	Effects of T cell-induced colonic inflammation on epithelial barrier function† 2010 ·Inflammatory Bowel Diseases ·Peter Suenaert, Philippe Maerten, Gert Van Assche, Willy Van Driessche, Karel Geboes, Veerle Bulteel, Jeannine Simaels, Patrick Augustijns, Jan Ceuppens, Paul Rutgeerts, Clémentine Perrier	21
6	Pouchitis, Similar to Active Ulcerative Colitis, Is Associated with Impaired Butyrate Oxidation by Intestinal Mucosa 2008 ·Inflammatory Bowel Diseases ·Vicky De Preter, Veerle Bulteel, Peter Suenaert, Karen Geboes, Gert De Hertogh, Anja Luypaerts, Karel Geboes, Kristin Verbeke, Paul Rutgeerts	27
7	Hyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent 2005 ·Inflammatory Bowel Diseases ·Peter Suenaert, Veerle Bulteel, Séverine Vermeire, Maja Noman, Gert Van Assche, Paul Rutgeerts	29
8	In vivo Influence of Nicotine on Human Basal and NSAID-induced Gut Barrier Function 2003 ·Scandinavian Journal of Gastroenterology ·Peter Suenaert, Veerle Bulteel, Elly Den Hond, Benny Geypens, (unknown), Anja Luypaerts, Yvo Ghoos, P. Rutgeerts	23
9	Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease 2002 ·The American Journal of Gastroenterology ·Peter Suenaert, Veerle Bulteel, Liesbeth Lemmens, Maja Noman, Benny Geypens, Gert Van Assche, Karel Geboes, Jan Ceuppens, Paul Rutgeerts	316
10	Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families 2001 ·Inflammatory Bowel Diseases ·Séverine Vermeire, Marc Peeters, Robert Vlietinck, Sofie Joossens, Elly Den Hond, Veerle Bulteel, Xavier Bossuyt, Benny Geypens, (unknown)	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact